Dr. Kozikowski is a leader in medicinal chemistry designing Novel Chemical Entities (NCEs) for oncology and neuroscience. The post PurMinds Appoints Leading...
Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed. The post News...
From the desk of Nick Kadysh, Founding CEO, PharmAla Biotech “I just did my MDMA-assisted therapy yesterday. This modality is going to save so many lives....
Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a pharmaceutical company developing cannabinoid pharmaceutical...
Colorado officials will hold online hearings to gather public opinions on Colorado’s efforts to implement psychedelic decriminalization measures. The...
Microdose is partnering with Concordia for the 2023 Concordia Annual Summit, taking place September 18-20 in New York City. The post Microdose Partners...
Awakn Life Sciences has submitted a Clinical Trial Application for a phase III trial for its lead program for the treatment of Severe Alcohol Use Disorder....
The overall anorexia nervosa market is expected to boost due to rising prevalence cases over the globe and thus the surge in treatment options. Along with...
A new study published in Nature shows that MDMA can reduce difficult experiences with other psychedelics. The post New Study Shows Candy-Flipping Can Reduce...
Investing in biotech stocks is not for the meek. Losses can be very large and occur very quickly. In fact, I’ve uncovered seven of the top...